Jonathan Siegal sold $220k of VCEL
Principal Accounting Officer at Vericel Corp. 4,500 shares at an average of $48.90, traded Jul 30, 2026, filed Jul 31, 2026.
Score components
- +15RoleOfficer
- +12Trade size$220k at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-030487, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | MOption exercise Common Stock10b5-1 | +1,500 | $34.90 | $52k | 2,578 | Jul 31, 2026 |
| Jul 30, 2026 | SOpen-market sale Common Stock10b5-1 | -1,500 | $48.90 | $73k | 1,078 | Jul 31, 2026 |
| Jul 30, 2026 | MOption exercise Common Stock10b5-1 | +2,500 | $29.82 | $75k | 3,578 | Jul 31, 2026 |
| Jul 30, 2026 | SOpen-market sale Common Stock10b5-1 | -2,500 | $48.90 | $122k | 1,078 | Jul 31, 2026 |
| Jul 30, 2026 | MOption exercise Common Stock10b5-1 | +500 | $29.82 | $15k | 1,578 | Jul 31, 2026 |
| Jul 30, 2026 | SOpen-market sale Common Stock10b5-1 | -500 | $48.90 | $24k | 1,078 | Jul 31, 2026 |
| Jul 30, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +1,500 | $0.00 | $0 | 2,698 | Jul 31, 2026 |
| Jul 30, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +2,500 | $0.00 | $0 | 4,000 | Jul 31, 2026 |
| Jul 30, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | +500 | $0.00 | $0 | 3,500 | Jul 31, 2026 |
Related signals
Other insiders at Vericel Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 19Weak | Vericel Corp | Kevin F McLaughlin director | $312k 7,000 shares | -28% | |
| 27Weak | Vericel Corp | Michael Halpin Chief Operating Officer | $468k 10,000 shares | -38% | |
| 36Weak | Vericel Corp | Sean C. Flynn Chief Legal Officer | $685k 15,000 shares | -90% | |
| 17Weak | Vericel Corp | Jonathan Mark Hopper Chief Medical Officer | $450k 10,000 shares | -12% | |
| 34Weak | Vericel Corp | Joseph Anthony Mara Jr Chief Financial Officer | $224k 5,000 shares | -24% | |
| 25Weak | Vericel Corp | Jonathan Siegal Principal Accounting Officer | $123k 2,732 shares | -244% | |
| 34Weak | Vericel Corp | Sean C. Flynn Chief Legal Officer | $603k 15,000 shares | -90% | |
| 26Weak | Vericel Corp | Michael Halpin Chief Operating Officer | $402k 10,000 shares | -38% | |
| 0Weak | Vericel Corp | Jonathan Mark Hopper Chief Medical Officer | $153k 4,375 shares | -5% | |
| 18Weak | Vericel Corp | Kevin F McLaughlin director | $230k 7,000 shares | -32% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.